ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

in: Clinical cancer research : an official journal of the American Association for Cancer Research | Vol. 26, No. 9 (2020), p. 2244-2256

by Okura, N. | Nishioka, N. | Yamada, T. | +19